Bone Strength/Bone Mass Discrepancy in Glucocorticoid-Treated Adult Mice

Autor: Dubrovsky, Alanna M, Nyman, Jeffrey S, Uppuganti, Sasidhar, Chmiel, Kenneth J, Kimmel, Donald B, Lane, Nancy E

Publikováno v: JBMR plus, vol 5, iss 3

Glucocorticoids increase bone fragility in patients in a manner that is underestimated by bone mass measurement. This study aimed to determine if the adult mouse could model this bone strength/bone mass discrepancy. Forty-two 13-week-old BALB/cJ mice

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a8c5c8a401a36ec13800d61ff48df171
https://escholarship.org/uc/item/64z2s5f3

Statins, Fibrates, and Other Peroxisome Proliferator-Activated Receptor Agonists for the Treatment of Cholestatic Liver Diseases.

Autor: Dubrovsky, Alanna M. K., Bowlus, Christopher L.

Publikováno v: Gastroenterology & Hepatology; Jan2020, Vol. 16 Issue 1, p31-38, 8p

Bone Strength/Bone Mass Discrepancy in Glucocorticoid-Treated Adult Mice.

Autor: Dubrovsky AM; Center for Musculoskeletal Health University of California at Davis Medical Center Sacramento CA USA., Nyman JS; Department of Orthopaedic Surgery Vanderbilt University Medical Center Nashville TN USA., Uppuganti S; Department of Orthopaedic Surgery Vanderbilt University Medical Center Nashville TN USA., Chmiel KJ; Center for Musculoskeletal Health University of California at Davis Medical Center Sacramento CA USA., Kimmel DB; Department of Physiological Sciences University of Florida Gainesville FL USA., Lane NE; Center for Musculoskeletal Health University of California at Davis Medical Center Sacramento CA USA.

Publikováno v: JBMR plus [JBMR Plus] 2020 Dec 21; Vol. 5 (3), pp. e10443. Date of Electronic Publication: 2020 Dec 21 (Print Publication: 2021).